MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchFAQAbout
Home/
SGMO - Sangamo Therapeutics Inc3:00:16 PM 4/25/2024
Price
$0.48
-0.01 (-2.13%)
Sangamo Therapeutics, Inc. is an American biotechnology company based in Brisbane, California. It applies cell and gene therapy to combat haemophilia and other genetic diseases. The company was founded in 1995 in Richmond, California. It was originally known as Sangamo Biosciences, Inc. before changing names in 2017. In September 2018, it had 182 employees. Sandy Macrae is the president. In 2018, Edward Rebar became the senior vice president and chief technology officer of Sangamo.
Financials
Quarterly financials
(USD)Dec 2023Q/Q
Revenue2MM-78%
Operating Income-62.1MM-42%
Operating Expenses64.1MM-45%
Net Income--
R&D50.7MM-11%
G&A13.1MM-6%
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Related
Topics
Gene Therapy-1.30%
Biotechnology-1.10%
Peers
ALNY-1.60%
AMGN-0.20%
BIIB4.60%
BMRN-0.90%
DOW0.40%
GILD0.10%
JNJ-0.70%
MRK0.10%
leak data
Stock news

Load more